Publications

  1. Bakkum-Gamez JN, Dowdy SC, Borah BJ, Haas LR, Mariani A, Martin JR, Weaver AL, McGree ME, Cliby WA, Podratz KC. Predictors and costs of surgical site infections in patients with endometrial cancer. Gynecol Oncol. 2013 Jul; 130(1):100-6. Epub 2013 Apr 02. 2315038
    View PubMed
  2. Kumar S, Al-Wahab Z, Sarangi S, Woelk J, Morris R, Munkarah A, Dowdy SC, Mariani A, Cliby W. Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and cervical cancer is low: A multi-institutional study. Gynecol Oncol. 2013 Jul; 130(1):207-12. Epub 2013 Apr 20. 2319126
    View PubMed
  3. Allensworth SK, Langstraat CL, Martin JR, Lemens MA, McGree ME, Weaver AL, Dowdy SC, Podratz KC, Bakkum-Gamez JN. Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer. Gynecol Oncol. 2013 Jun 05. [Epub ahead of print] 2330126
    View PubMed
  4. Kumar S, Mariani A, Bakkum-Gamez JN, Weaver AL, McGree ME, Keeney GL, Cliby WA, Podratz KC, Dowdy SC. Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer. Gynecol Oncol. 2013 Jun 04. [Epub ahead of print] 2329988
    View PubMed
  5. Ayeni TA, Bakkum-Gamez JN, Mariani A, McGree ME, Weaver AL, Haddock MG, Keeney GL, Long HJ 3rd, Dowdy SC, Podratz KC. Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas. Gynecol Oncol. 2013 Jun; 129(3):478-85. Epub 2013 Mar 25. 2313151
    View PubMed
  6. Yost KJ, Cheville AL, Weaver AL, Al Hilli M, Dowdy SC. Development and validation of a self-report lower-extremity lymphedema screening questionnaire in women. Phys Ther. 2013 May; 93(5):694-703. Epub 2013 Jan 03. 2294172
    View PubMed
  7. Kalogera E, Dowdy SC, Mariani A, Weaver AL, Aletti G, Bakkum-Gamez JN, Cliby WA. Multiple large bowel resections: Potential risk factor for anastomotic leak. Gynecol Oncol. 2013 Apr 08. [Epub ahead of print] 2316568
    View PubMed
  8. Barney BM, Petersen IA, Dowdy SC, Bakkum-Gamez JN, Klein KA, Haddock MG. Intraoperative electron beam radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer. Radiat. oncol. 2013 Apr 8; 8:80. 2329796
  9. AlHilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, Kumar S, Keeney GL, Cliby WA, Mariani A. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol. 2013 Feb; 128(2):294-9. Epub 2012 Oct 17. 2278585
    View PubMed
  10. Barney BM, Petersen IA, Mariani A, Dowdy SC, Bakkum-Gamez JN, Haddock MG. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer. Int J Radiat Oncol Biol Phys. 2013 Jan 1; 85(1):109-15. Epub 2012 Apr 28. 2242156
    View PubMed
  11. Ayeni TA, Bakkum-Gamez JN, Mariani A, McGree ME, Weaver AL, Alhilli MM, Martin JR, Keeney GL, Dowdy SC, Podratz KC. Impact of tubal ligation on routes of dissemination and overall survival in uterine serous carcinoma. Gynecol Oncol. 2013 Jan; 128(1):71-6. Epub 2012 Nov 02. 2281833
    View PubMed
  12. Getz G, Gabriel SB, Cibulskis K, Lander E, Sivachenko A, Sougnez C, Lawrence M, Kandoth C, Dooling D, Fulton R, Fulton L, Kalicki-Veizer J, McLellan MD, O'Laughlin M, Schmidt H, Wilson RK, Ye K, Li D, Ally A, Balasundaram M, Birol I, Butterfield YSN, Integrated genomic characterization of endometrial carcinoma. Nature. 2013; 497(7447):67-73. 2326355
  13. Li J, Chen H, Mariani A, Chen D, Klatt E, Podratz K, Drapkin R, Broaddus R, Dowdy S, Jiang SW. HE4 (WFDC2) promotes tumor growth in endometrial cancer cell lines. Int. J. Mol. Sci. 2013; 14(3):6026-43. 2316306
  14. Mader EK, Butler G, Dowdy SC, Mariani A, Knutson KL, Federspiel MJ, Russell SJ, Galanis E, Dietz AB, Peng KW. Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer. J Transl Med. 2013; 11:20. Epub 2013 Jan 24. 2302528
    View PubMed
  15. Alhilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, Kumar S, Keeney GL, Cliby WA, Mariani A. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Obstet Gynecol Surv. 2013; 68(3):199-200. 2313531
  16. Fotopoulou C, Zang R, Gultekin M, Cibula D, Ayhan A, Liu D, Richter R, Braicu I, Mahner S, Harter P, Trillsch F, Kumar S, Peiretti M, Dowdy SC, Maggioni A, Trope C, Sehouli J. Value of tertiary cytoreductive surgery in epithelial ovarian cancer: An international multicenter evaluation. Ann Surg Oncol. 2013; 20(4):1348-54. 2316221
  17. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Kumar S, Weaver AL, McGree ME, Haas LR, Cliby WA, Podratz KC. Factors predictive of postoperative morbidity and cost in patients with endometrial cancer. Obstet Gynecol. 2012 Dec; 120(6):1419-27. 2285319
    View PubMed
  18. Kumar S, Medeiros F, Dowdy SC, Keeney GL, Bakkum-Gamez JN, Podratz KC, Cliby WA, Mariani A. A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. Gynecol Oncol. 2012 Dec; 127(3):525-31. Epub 2012 Aug 29. 2267996
    View PubMed
  19. Geels YP, Pijnenborg JM, van den Berg-van Erp SH, Bulten J, Visscher DW, Dowdy SC, Massuger LF. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis. Obstet Gynecol. 2012 Nov; 120(5):1124-31. 2279333
    View PubMed
  20. Torres ML, Weaver AL, Kumar S, Uccella S, Famuyide AO, Cliby WA, Dowdy SC, Gostout BS, Mariani A. Risk factors for developing endometrial cancer after benign endometrial sampling. Obstet Gynecol. 2012 Nov; 120(5):998-1004. 2279334
    View PubMed
  21. Fotopoulou C, Zang R, Gultekin M, Cibula D, Ayhan A, Liu D, Richter R, Braicu I, Mahner S, Harter P, Trillsch F, Kumar S, Peiretti M, Dowdy SC, Maggioni A, Trope C, Sehouli J. Value of Tertiary Cytoreductive Surgery in Epithelial Ovarian Cancer: An International Multicenter Evaluation. Ann Surg Oncol 2 [Epub ahead of print]23054114. 2012 Oct 2; PMID. 2299657
  22. Bakkum-Gamez JN, Chien J, Clayton AC, Halling KC, Cliby WA, Dowdy SC, Kipp BR, Famuyide A, Mariani A, Oberg AL, Wentzensen N, Sherman M, Podratz KC, Shridhar V. Development of biomarkers in endometrial cancer and its precursor lesions. J Womens Health. 2012 Oct; 21(10):1004. 2298801
  23. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR, Keeney GL, Mariani A, Podratz KC. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol. 2012 Oct; 127(1):5-10. Epub 2012 Jul 03. 2257014
    View PubMed
  24. Kalogera E, Dowdy SC, Mariani A, Aletti G, Bakkum-Gamez JN, Cliby WA. Utility of closed suction pelvic drains at time of large bowel resection for ovarian cancer. Gynecol Oncol. 2012 Sep; 126(3):391-6. Epub 2012 May 20. 2247909
    View PubMed
  25. Tolcher MC, Kalogera E, Hopkins MR, Weaver AL, Bingener J, Dowdy SC. Safety of culdotomy as a surgical approach: implications for natural orifice transluminal endoscopic surgery. JSLS. 2012 Jul-Sep; 16(3):413-20. 2296273
    View PubMed
  26. Bakkum-Gamez JN, Langstraat CL, Martin JR, Lemens MA, Weaver AL, Allensworth S, Dowdy SC, Cliby WA, Gostout BS, Podratz KC. Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian carcinoma. Gynecol Oncol. 2012 Jun; 125(3):614-20. Epub 2012 Feb 24. 2227725
    View PubMed
  27. Barney BM, Petersen IA, Dowdy SC, Bakkum-Gamez JN, Haddock MG. Long-term outcomes with intraoperative radiotherapy as a component of treatment for locally advanced or recurrent uterine sarcoma. Int J Radiat Oncol Biol Phys. 2012 May 1; 83(1):191-7. Epub 2011 Oct 08. 2197970
    View PubMed
  28. AlHilli MM, Dowdy SC, Weaver AL, St Sauver JL, Keeney GL, Mariani A, Podratz KC, Bakkum-Gamez JN. Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study. Gynecol Oncol. 2012 Apr; 125(1):109-13. Epub 2011 Dec 28. 2235827
    View PubMed
  29. Kalogera E, Scholler N, Powless C, Weaver A, Drapkin R, Li J, Jiang SW, Podratz K, Urban N, Dowdy SC. Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer. Gynecol Oncol. 2012 Feb; 124(2):270-5. Epub 2011 Oct 28. 2203510
    View PubMed
  30. Bakkum-Gamez JN, Kalogera E, Keeney GL, Mariani A, Podratz KC, Dowdy SC. Conservative management of atypical hyperplasia and grade i endometrial carcinoma: Review of the literature and presentation of a series. J Gynecol Surg. 2012; 28(4):262-9. 2270435
  31. Barney BM, Petersen IA, Dowdy SC, Bakkum-Gamez JN, Haddock MG. Intraoperative electron beam radiotherapy (IOERT) in the management of recurrent ovarian malignancies. Int J Gynecol Cancer. 2011 Oct; 21(7):1225-31. 2190669
    View PubMed
  32. Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Cliby WA, Gostout BS, Stanhope CR, Wilson TO, Podratz KC. The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer. Gynecol Oncol. 2011 Oct; 123(1):58-64. Epub 2011 Jul 13. 2176073
    View PubMed
  33. Crane LM, van Oosten M, Pleijhuis RG, Motekallemi A, Dowdy SC, Cliby WA, van der Zee AG, van Dam GM. Intraoperative imaging in ovarian cancer: fact or fiction? Mol Imaging. 2011 Aug; 10(4):248-57. Epub 2011 Apr 26. 2179546
    View PubMed
  34. Ren J, Singh BN, Huang Q, Li Z, Gao Y, Mishra P, Hwa YL, Li J, Dowdy SC, Jiang SW. DNA hypermethylation as a chemotherapy target. Cell Signal. 2011 Jul; 23(7):1082-93. Epub 2011 Feb 21. 2164209
    View PubMed
  35. Mariani A, El-Nashar SA, Dowdy SC. Lymphadenectomy in endometrial cancer: which is the right question? Int J Gynecol Cancer. 2010 Oct; 20(11 Suppl 2):S52-4. 2124072
    View PubMed
  36. Singh BN, Zhang G, Hwa YL, Li J, Dowdy SC, Jiang SW. Nonhistone protein acetylation as cancer therapy targets. Expert Rev Anticancer Ther. 2010 Jun; 10(6):935-54. 2106891
    View PubMed
  37. Dowdy SC, Mariani A. Lymphadenectomy in endometrial cancer: when, not if. Lancet. 2010 Apr 3; 375(9721):1138-40. Epub 2010 Feb 24. 1988620
    View PubMed
  38. Galanis E, Hartmann LC, Cliby WA, Long HJ, Peethambaram PP, Barrette BA, Kaur JS, Haluska PJ Jr, Aderca I, Zollman PJ, Sloan JA, Keeney G, Atherton PJ, Podratz KC, Dowdy SC, Stanhope CR, Wilson TO, Federspiel MJ, Peng KW, Russell SJ. Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. Cancer Res. 2010 Feb 1; 70(3):875-82. Epub 2010 Jan 26. 1983174
    View PubMed
  39. Mariani A, Cha SS, Bergstralh EJ, Boardman LA, Dowdy SC, Keeney GL, Podratz KC, Melton LJ 3rd. Referral and ascertainment bias in patients with synchronous and metachronous endometrial malignancy. Eur J Gynaecol Oncol. 2010; 31(1):5-9. 1995689
    View PubMed
  40. Li J, Dowdy S, Tipton T, Podratz K, Lu WG, Xie X, Jiang SW. HE4 as a biomarker for ovarian and endometrial cancer management. Expert Rev Mol Diagn. 2009 Sep; 9(6):555-66. 1968268
    View PubMed
  41. Marnitz S, Dowdy S, Lanowska M, Schneider A, Podratz K, Kohler C. Exenterations 60 years after first description: results of a survey among US and German Gynecologic Oncology Centers. Int J Gynecol Cancer. 2009 Jul; 19(5):974-7. 1966070
    View PubMed
  42. Liu P, Khurana A, Rattan R, He X, Kalloger S, Dowdy S, Gilks B, Shridhar V. Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer. Cancer Res. 2009 Jun 1; 69(11):4843-50. 1962671
    View PubMed
  43. Mariani A, Dowdy SC, Podratz KC. New surgical staging of endometrial cancer: 20 years later. Int J Gynaecol Obstet. 2009 May; 105(2):110-1. Epub 2009 Mar 14. 1931922
    View PubMed
  44. Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope RC, Wilson TO, Podratz KC, Cliby WA. Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience. J Am Coll Surg. 2009 Apr; 208(4):614-20. 1944142
    View PubMed
  45. Thomas MB, Keeney GL, Podratz KC, Dowdy SC. Endometrial stromal sarcoma: treatment and patterns of recurrence. Int J Gynecol Cancer. 2009 Feb; 19(2):253-6. 1938369
    View PubMed
  46. Konecny GE, Santos L, Winterhoff B, Hatmal M, Keeney GL, Mariani A, Jones M, Neuper C, Thomas B, Muderspach L, Riehle D, Wang HJ, Dowdy S, Podratz KC, Press MF. HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer. Br J Cancer. 2009 Jan 13; 100(1):89-95. Epub 2008 Dec 16. 1915087
    View PubMed
  47. Mariani A, Dowdy S, Podratz K. Views and counter views. The role of pelvic and para-aortic lymph node dissection in the surgical treatment of endometrial cancer: A view from the USA The Obstetrician and Gynaecologist. 2009; 11(3):199-204. 1959890
  48. Winterhoff BJ, Bakkum-Gamez JN, Mariani A, Dowdy SC. Special cases of endometrial carcinoma : FFertility retention and prevention in high-risk patients. [German]. Onkologe. 2009; 15(9):904-11. 1978990
  49. Uccella S, Dowdy SC, Mariani A. Disease-oriented individual postoperative therapy for female patients with endometrial cancinoma. [German]. Onkologe. 2009; 15(9):877-84. 1978991
  50. Dowdy SC, Aletti G, Cliby WA, Podratz KC, Mariani A. Extra-peritoneal laparoscopic para-aortic lymphadenectomy--a prospective cohort study of 293 patients with endometrial cancer. Gynecol Oncol. 2008 Dec; 111(3):418-24. Epub 2008 Oct 02. 1915576
    View PubMed
  51. Jiang SW, Li J, Podratz K, Dowdy S. Application of DNA methylation biomarkers for endometrial cancer management. Expert Rev Mol Diagn. 2008 Sep; 8(5):607-16. 1955122
    View PubMed
  52. Dozois EJ, Larson DW, Dowdy SC, Poola VP, Holubar SD, Cima RR. Transvaginal colonic extraction following combined hysterectomy and laparoscopic total colectomy: a natural orifice approach. Tech Coloproctol. 2008 Sep; 12(3):251-4. Epub 2008 Aug 05. 1931434
    View PubMed
  53. Thomas MB, Wright JD, Leiser AL, Chi DS, Mutch DG, Podratz KC, Dowdy SC. Clear cell carcinoma of the cervix: a multi-institutional review in the post-DES era. Gynecol Oncol. 2008 Jun; 109(3):335-9. Epub 2008 Apr 03. 1883244
    View PubMed
  54. Dowdy SC, Loewen RT, Aletti G, Feitoza SS, Cliby W. Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma. Gynecol Oncol. 2008 May; 109(2):303-7. Epub 2008 Apr 01. 1883029
    View PubMed
  55. Konecny GE, Agarwal R, Keeney GA, Winterhoff B, Jones MB, Mariani A, Riehle D, Neuper C, Dowdy SC, Wang HJ, Morin PJ, Podratz KC. Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer. Gynecol Oncol. 2008 May; 109(2):263-9. Epub 2008 Mar 07. 1883030
    View PubMed
  56. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, Podratz KC. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008 Apr; 109(1):11-8. Epub 2008 Mar 04. 1872078
    View PubMed
  57. Thomas M, Mariani A, Wright JD, Madarek EO, Powell MA, Mutch DG, Podratz KC, Dowdy SC. Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review. Gynecol Oncol. 2008 Feb; 108(2):293-7. Epub 2007 Dec 21. 1861307
    View PubMed
  58. Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC. Current issues in the management of endometrial cancer. Mayo Clin Proc. 2008 Jan; 83(1):97-112. 1867485
    View PubMed
  59. Mariani A, Dowdy S, Podratz K. Surgical Treatment of Endometrial Cancer: the Role of Pelvic and Para-aortic Lymph Node Dissection (A View from the USA). The Obstetrician & Gynaecologist 2008. Epub In press. 1860491
  60. Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol. 2007 Dec; 197(6):676.e1-7. 1853495
    View PubMed
  61. Dowdy SC, Mariani A, Bakkum JN, Cliby WA, Keeney GL, Podratz KC. Treatment of pulmonary recurrences in patients with endometrial cancer. Gynecol Oncol. 2007 Nov; 107(2):242-7. Epub 2007 Sep 17. 1853524
    View PubMed
  62. Thomas MB, Mariani A, Cliby WA, Keeney GL, Podratz KC, Dowdy SC. Role of cytoreduction in stage III and IV uterine papillary serous carcinoma. Gynecol Oncol. 2007 Nov; 107(2):190-3. Epub 2007 Sep 06. 1853525
    View PubMed
  63. Thomas MB, Mariani A, Cliby WA, Keeney GA, Podratz KC, Dowdy SC. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Gynecol Oncol. 2007 Nov; 107(2):186-9. Epub 2007 Aug 3. 1853526
    View PubMed
  64. Zhou XC, Dowdy SC, Podratz KC, Jiang SW. Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment. Gynecol Oncol. 2007 Oct; 107(1):143-53. Epub 2007 Aug 13. 1977434
    View PubMed
  65. Jiang S, Dowdy SC, Meng XW, Wang ZY, Jones MB, Podratz KC, Jiang SW. Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells. Gynecol Oncol. 2007 May; 105(2):493-500. 1824625
    View PubMed
  66. Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Analysis of factors impacting operability in stage IV ovarian cancer: rationale use of a triage system. Gynecol Oncol. 2007 Apr; 105(1):84-9. 1818771
    View PubMed
  67. Axtell AE, Lee MH, Bristow RE, Dowdy SC, Cliby WA, Raman S, Weaver JP, Gabbay M, Ngo M, Lentz S, Cass I, Li AJ, Karlan BY, Holschneider CH. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol. 2007 Feb 1; 25(4):384-9. 1807140
    View PubMed
  68. Aletti GD, Dowdy S, Podratz KC, Cliby WA. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Am J Obstet Gynecol. 2006 Dec; 195(6):1862-8. 1796760
    View PubMed
  69. Dowdy SC, Jiang S, Zhou XC, Hou X, Jin F, Podratz KC, Jiang SW. Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells. Mol Cancer Ther. 2006 Nov; 5(11):2767-76. 1792954
    View PubMed
  70. Xiong Y, Dowdy SC, Eberhardt NL, Podratz KC, Jiang SW. hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications. Gynecol Oncol. 2006 Oct; 103(1):321-8. Epub 2006 May 15. 1786776
    View PubMed
  71. Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG, Podratz KC. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol. 2006 May; 101(2):200-8. Epub 2006 Feb 28. 1765186
    View PubMed
  72. Dowdy SC, Mariani A, Cliby WA, Haddock MG, Petersen IA, Sim FH, Podratz KC. Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes. Gynecol Oncol. 2006 May; 101(2):280-6. 1765187
    View PubMed
  73. Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol. 2006 Feb; 100(2):283-7. Epub 2005 Sep 22. 1747102
    View PubMed
  74. Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, Wilson TO, Podratz KC, Cliby WA. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol. 2006 Jan; 107(1):77-85. 1744124
    View PubMed
  75. Mariani A, Dowdy SC, Podratz KC. Outcomes of pulmonary failures in women with endometrial cancer. Gynecol Oncol Manuscript in progress. 2006. 1751739
  76. Xiong Y, Dowdy SC, Gonzalez Bosquet J, Zhao Y, Eberhardt NL, Podratz KC, Jiang SW. Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines. Gynecol Oncol. 2005 Oct; 99(1):135-41. 1977487
    View PubMed
  77. Dowdy SC, Gostout BS, Shridhar V, Wu X, Smith DI, Podratz KC, Jiang SW. Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines. Gynecol Oncol. 2005 Oct; 99(1):126-34. 1732104
    View PubMed
  78. Mariani A, Sebo TJ, Katzmann JA, Riehle DL, Dowdy SC, Keeney GL, Lesnick TG, Podratz KC. HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature. Anticancer Res. 2005 Jul-Aug; 25(4):2921-7. 1726778
    View PubMed
  79. Mariani A, Dowdy SC, Keeney GL, Haddock MG, Lesnick TG, Podratz KC. Predictors of vaginal relapse in stage I endometrial cancer. Gynecol Oncol. 2005 Jun; 97(3):820-7. 1720471
    View PubMed
  80. Xiong Y, Dowdy SC, Podratz KC, Jin F, Attewell JR, Eberhardt NL, Jiang SW. Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells. Cancer Res. 2005 Apr 1; 65(7):2684-9. 1705094
    View PubMed
  81. Xiong YN, Dowdy SC, Xue AL, Jiang SJ, Eberhardt NL, Podratz KC, Jiang SW. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. Gynecol Oncol. 2005 Mar; 96(3):601-9. 1703797
    View PubMed
  82. Dowdy SC, Mariani A, Reinholz MM, Keeney GL, Spelsberg TC, Podratz KC, Janknecht R. Overexpression of the TGF-beta antagonist Smad7 in endometrial cancer. Gynecol Oncol. 2005 Feb; 96(2):368-73. 1694087
    View PubMed
  83. Dowdy SC, Metzinger DS, Gebhart JB, Srivatsa P, Haddock MG, Suman VJ, Podratz KC. Salvage whole-abdominal radiation therapy after second-look laparotomy or secondary debulking surgery in patients with ovarian cancer. Gynecol Oncol. 2005 Feb; 96(2):389-94. 1694088
    View PubMed
  84. Jin F, Dowdy SC, Xiong Y, Eberhardt NL, Podratz KC, Jiang SW. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers. Gynecol Oncol. 2005 Feb; 96(2):531-8. 1694089
    View PubMed
  85. Mariani A, Dowdy SC, Keeney GL, Long HJ, Lesnick TG, Podratz KC. High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy. Gynecol Oncol. 2004 Oct; 95(1):120-6. 1667521
    View PubMed
  86. Dowdy SC, Stefanek M, Hartmann LC. Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy. Am J Obstet Gynecol. 2004 Oct; 191(4):1113-23. 1673835
    View PubMed
  87. Cliby W, Dowdy S, Feitoza SS, Gostout BS, Podratz KC. Diaphragm resection for ovarian cancer: technique and short-term complications. Gynecol Oncol. 2004 Sep; 94(3):655-60. 1665762
    View PubMed
  88. Dowdy SC, Mullany SA, Brandt KR, Huppert BJ, Cliby WA. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer. 2004 Jul 15; 101(2):346-52. 1653796
    View PubMed
  89. Dowdy SC, Constantinou CL, Hartmann LC, Keeney GL, Suman VJ, Hillman DW, Podratz KC. Long-term follow-up of women with ovarian cancer after positive second-look laparotomy. Gynecol Oncol. 2003 Dec; 91(3):563-8. 1431552
    View PubMed
  90. Dowdy SC, Mariani A, Janknecht R. HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81. J Biol Chem. 2003 Nov 7; 278(45):44377-84. Epub 2003 Aug 28. 1422421
    View PubMed
  91. Dowdy SC, Cliby WA. Preparing for the unexpected: encountering gynecologic problems when operating for colon cancer. Current Surgery. 2003 Jan; 60(1):12-16. 1648140
    View PubMed
  92. Dowdy SC, Boardman CH, Wilson TO, Podratz KC, Hartmann LC, Long HJ. Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancer. Am J Obstet Gynecol. 2002 Jun; 186(6):1167-73. 1316065
    View PubMed
  93. Dowdy SC, O'Kane DJ, Keeney GL, Boyd J, Podratz KC. Telomerase activity in sex cord-stromal tumors of the ovary. Gynecol Oncol. 2001 Aug; 82(2):257-60. 1014895
    View PubMed
  94. Dowdy SC, Pfeifer EA, Longcope DC, Cliby WA. Unusual recurrence of ovarian carcinoma 9 years after initial diagnosis. Gynecol Oncol. 1999 Sep; 74(3):495-8. 1009586
    View PubMed